Literature DB >> 12740307

Risk of cancers in COPD patients.

Mika Nakayama, Hiroaki Satoh, Kiyohisa Sekizawa.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12740307     DOI： 10.1378/chest.123.5.1775-a

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  Features of COPD as Predictors of Lung Cancer.

Authors:  Tomohiro Tamura; Kunihiko Miyazaki; Hiroaki Satoh
Journal:  Chest       Date:  2018-09       Impact factor: 9.410

2.  Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease.

Authors:  Chi-Lu Chiang; Yu-Wen Hu; Chieh-Hung Wu; Yung-Tai Chen; Chia-Jen Liu; Yung-Hung Luo; Yuh-Min Chen; Tzeng-Ji Chen; Kang-Cheng Su; Kun-Ta Chou
Journal:  Int J Clin Oncol       Date:  2016-05-06       Impact factor: 3.402

3.  Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer.

Authors:  Mathewos Tessema; Christin M Yingling; Maria A Picchi; Guodong Wu; Yushi Liu; Joel L Weissfeld; Jill M Siegfried; Yohannes Tesfaigzi; Steven A Belinsky
Journal:  J Thorac Oncol       Date:  2015-08       Impact factor: 15.609

4.  Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients.

Authors:  Mathewos Tessema; Dereje D Tassew; Christin M Yingling; Kieu Do; Maria A Picchi; Guodong Wu; Hans Petersen; Scott Randell; Yong Lin; Steven A Belinsky; Yohannes Tesfaigzi
Journal:  Lung Cancer       Date:  2020-05-25       Impact factor: 5.705

5.  Incidence and relative risk for developing cancer among patients with COPD: a nationwide cohort study in Taiwan.

Authors:  Chung-Han Ho; Yi-Chen Chen; Jhi-Joung Wang; Kuang-Ming Liao
Journal:  BMJ Open       Date:  2017-03-09       Impact factor: 2.692

6.  The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer.

Authors:  Aiping Ma; Guangdong Wang; Yan Du; Weixi Guo; Jiaxi Guo; Yi Hu; Dongyu Bai; Huiping Huang; Lianjin Zhuang; Jinhan Chen; Qun Liu
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.